Targeting TBXAS1: a novel target of daidzein in alleviating APAP-induced hepatic injury
Lei Sun(Affiliated Hospital of Southwest Medical University), Wenguang Fu(Southwest Medical University), Shenglu Liu(Affiliated Hospital of Southwest Medical University), Jiatong Chen(Affiliated Hospital of Southwest Medical University), Yu Jiang(AstraZeneca (Japan)), Zhiwei Huang(Affiliated Hospital of Southwest Medical University), Yichao Du(Affiliated Hospital of Southwest Medical University), Han Li(Liuzhou General Hospital), Xiaolin Zhong, Pengru Wang(Affiliated Hospital of Southwest Medical University), Boyuan Gu(Affiliated Hospital of Southwest Medical University), Ziming Wu(Affiliated Hospital of Southwest Medical University)
Cited by 1
Related Papers
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment
|Nature Communications|2020|478
Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study
|The Lancet Digital Health|2022|161
MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF
|Oncogene|2017|141
Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer
|International Journal of Nanomedicine|2017|128